| |
 |
Recent Advances Involving Palladium (II) Complexes for the Cancer Therapy
|
| |
|
pp.484-491 (8) Author: Antonio Carlos Favero Caires |
| |
|
|
| |
|
Oncologists' Current Opinion on the Treatment of Colon Carcinoma
|
| |
|
pp.492-503 (12) Authors: Martin Majer, Wallace Akerley, Scott K. Kuwada |
| |
|
|
| |
|
Targeting Aberrant TGF-β Signaling in Pre-Clinical Models of Cancer
|
| |
|
pp.504-514 (11) Authors: Anna Alexeyevna Mourskaia, Jason Jonathan Northey, Peter Michael Siegel |
| |
|
|
| |
|
PARP Inhibitor Development for Systemic Cancer Targeting
|
| |
|
pp.515-523 (9) Authors: Tomasz Zaremba, Nicola Jane Curtin |
| |
|
|
| |
|
Recent Advances in Classical and Non-Classical Antifolates as Antitumor and Antiopportunistic Infection Agents: Part I
|
| |
|
pp.524-542 (19) Authors: Aleem Gangjee, Hiteshkumar D. Jain, Sonali Kurup |
| |
|
|
| |
|
Development and Application of Peptide-Based Radiopharmaceuticals
|
| |
|
pp.543-551 (9) Authors: Ingrid Dijkgraaf, Otto C. Boerman, Wim J.G. Oyen, Frans H.M. Corstens, Martin Gotthardt |
| |
|
|
| |
|
Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
|
| |
|
pp.552-558 (7) Authors: Elisabeth Garanger, Didier Boturyn, Pascal Dumy |
| |
|
|
| |
|
Polyphenolic Coumpounds in Chemoprevention of Colon Cancer - Targets and Signaling Pathways
|
| |
|
pp.559-575 (17) Authors: Emil Rudolf, Hana Andelova, Miroslav Cervinka |
| |
|
|
| |
|
Histone Deacetylase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective
|
| |
|
pp.576-592 (17) Authors: Konstantin V. Balakin, Yan A. Ivanenkov, Alex S. Kiselyov, Sergey E. Tkachenko |
| |
|
|
